Physician profile
Eve Cusick
NPI 1891145330
$6,109.74
in general payments reported to CMS, 2019-2025
26 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $608 · 2022: $1,037 · 2023: $792 · 2024: $1,681 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,409 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,408.76 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,578.64 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,270.29 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.49 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| Genzyme Corporation | $411.17 | 2021-2025 | |
| Amgen INC. | $361.12 | 2022-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $316.36 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $307.31 | 2021-2024 | Yupelri |
| Grifols USA, LLC | $240.06 | 2021-2025 | Prolastin-C Liquid |
| Philips North America LLC | $193.61 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Harmony Biosciences LLC | $191.79 | 2023-2025 | Wakix |
| Insmed, INC. | $159.25 | 2023-2025 | Arikayce |
| Jazz Pharmaceuticals INC. | $115.93 | 2024-2025 | |
| Verona Pharma, INC. | $100.94 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $83.91 | 2024-2025 | Tyvaso, Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $58.56 | 2022-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $57.96 | 2025 | Yupelri |
| Horizon Therapeutics Plc | $50.65 | 2021-2022 | |
| Baxter Healthcare | $44.92 | 2022 | |
| Advanced Respiratory, INC | $29.98 | 2021 | |
| Merck Sharp & Dohme LLC | $24.38 | 2025 | Keytruda |
| Abiomed | $15.64 | 2025 | |
| Ucb, INC. | $15.51 | 2021 | |
| Mallinckrodt Hospital Products INC. | $15.19 | 2025 | Acthar |
| Lilly USA, LLC | $14.98 | 2025 | Zepbound |
| Pulmonx Corporation | $14.66 | 2022 | |
| Csl Behring | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eve Cusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.